Trial
NCT06522854
Oral Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Alabama at Birmingham
Collaborators
University of Lagos, Nigeria; Ladoke Akintola University of Technology Teaching Hospital, Ogbomoso; Lagos State University; National Health and Medical Research Council, Australia; Mater Medical Research Institute; The University of Queensland
Condition
Intrapartum Fetal Distress
Intervention
Sildenafil 50 mg Oral Tablet
Why stopped
Funding not obtained
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-16